Does surgical treatment of BPH (benign enlargement not prostate cancer) cause sexual dysfunction?


Patient’s will commonly confuse the side effects of the surgery of prostate enlargement (difficulty voiding, frequency, small and slow stream, getting up at night) with that of prostate cancer surgery (leakage of urine and deterioration of sexual function).

This is not surprising as in general terms a surgical therapy is being done to the prostate and you’d think the side effects would be similar. However, in cancer surgery the entire gland is removed and in prostate enlargement the channel through the prostate where the urine flows is opened. As a result in BPH surgery (TURP, Button vaporization, GreenLight Laser) opens the channel to improve voiding but does not affect the continence mechanism or the nerves that impact potency. Surgery of the prostate for enlargement does cause retrograde ejaculation (the fluid at time of ejaculation does not come out at all or not as forcibly) but this was not found to have any impact.

The following study confirms this.

Surgical Management of BPH Does Not Reduce Sexual Function

Urology – August 1, 2006 – Vol. 21 – No. 12

Surgical management of BPH does not result in poorer sexual function, nor is there a difference between HoLEP and TURP.

Article Reviewed: Impact on Sexual Function of Holmium Laser Enucleation Versus Transurethral Resection of the Prostate: Results of a Prospective, 2-Center, Randomized Trial. Briganti A, Naspro R, et al: J Urol; 2006; 175 (May): 1817-1821.

Impact on Sexual Function of Holmium Laser Enucleation Versus Transurethral Resection of the Prostate: Results of a Prospective, 2-Center, Randomized Trial.

Briganti A, Naspro R, et al:
J Urol; 2006; 175 (May): 1817-1821

Background: Mixed data exist in the literature on the effect of surgical intervention for benign prostatic hyperplasia (BPH) on sexual function. Design/Objective: This randomized, controlled trial compared the impact of holmium laser enucleation (HoLEP) and transurethral resection of the prostate (TURP) on sexual function. Participants/Methods: 120 patients with BPH and lower urinary tract symptoms were randomized to either HoLEP or TURP (60 patients in each group). The patients were followed up and completed the validated sexual function inventory in the International Index of Erectile Function (IIEF), as well as a series of global assessment questions at 12 and 24 months postoperatively. The patient groups were matched for International Prostatic Symptom Score (IPSS) and quality of life (QOL) scores at baseline (21 and 4.5, respectively). The HoLEP group had a larger prostate volume (73 g) than did the TURP group (58 g). The baseline erectile function scores were similar between the 2 groups (21.8 vs 22.1; >25 indicates no erectile dysfunction [ED]), with approximately 50% of patients in both groups having some degree of ED preoperatively. The pharmacological treatment profiles prior to surgery were similar for both groups. Results: At 12 and 24 months after intervention, there was a slight, but statistically insignificant, increase in IIEF erectile function domain score in both groups (approximately a 1.5-point increase), with no difference in scores or degree of improvement between either surgical group. Furthermore, there was no difference in the incidence of retrograde ejaculation between groups. Of note, orgasm function (as scored by the IIEF) was decreased in both groups to a similar extent. There was a strong positive correlation between postoperative IPSS and QOL scores and the erectile function improvement, suggesting that the improvement in urinary function may be integral to sexual function improvement. Conclusions: Surgical intervention for BPH in the forms of HoLEP and TURP had no significant negative effect on erectile function, and no difference was found between the 2 surgical modalities. Reviewer’s Comments: This excellently conducted study sheds significant light on the fact that surgical treatment of BPH likely has little impact on sexual function. Indeed, in some men, function may improve. The inclusion of a validated questionnaire is a major strength of this study. Of note, the reduced orgasm function domain scores are most probably indicative of the nature of orgasm assessment using the IIEF. The questionnaire has only 2 questions on orgasm, one of which pertains to ejaculation. Thus, after surgical management of BPH, the IIEF would not be considered an adequate assessment tool for orgasm. It is worth noting that 50% of men had ED at baseline; therefore, it is conceivable that, in a population of patients with full erectile function at baseline, these results might be different, perhaps even a greater postoperative improvement in erectile function. (Reviewer–John P. Mulhall, MD).


Fall is in the air…bladder healthy soup?


Take advantage of the extra time you spend inside this winter to make some tasty meals. Here is a recipe for Chicken and White Bean Soup. It’s made with ‘good for you’ ingredients – and won’t bother a sensitive bladder.

Makes 6 servings, 1 ½ cups each
Calories per serving: 172

Read More…

Need an appointment? Contact us 24/7 and leave your number and we’ll call by the next business day.

Northeast Georgia Urology-GreenLight Laser.

download (2)

Northeast Georgia Urological Associates have experienced urologists who perform the GreenLight laser on a regular basis in our ambulatory surgery center.

 Contact us if you have trouble voiding and medicines for prostate enlargement are not working.

About Beethoven’s Symphony No. 9


Cialis-the new male wonder drug?


  • Cialis is a PDE-5 drug that is approved for the use of both erectile dysfunction and BPH (prostate enlargement).
  • PDE-5’s dilate the smooth muscle in blood vessels which causes  increased blood flow.
  • Because there is smooth muscle in the corpora of the penis, dilation of the blood vessels aids in erections.
  • Because there is smooth muscle in the area of the bladder neck and prostate, this also improves the flow of urine in the male with an enlarged prostate.
  • Because there is smooth muscle in the ureters, durgs like Cialis improve the chances of passing a ureteral stone (now referred to as expulsion therapy).
  • Other drugs in this class have been approved for pulmonary hypertension due to the smooth muscle effect.
  • Because nitroglycerin is a blood vessel dilator, it is contraindicated to use drugs like Cialis in a patient with heart disease and may need to take nitroglycerine.

If you add in the fact the drug only acts when it is needed by the male and that it has an effect for 36 hrs…you might agree that Cialis is indeed the new…Vitamin C.